Display options
Share it on

Arch Med Sci. 2016 Apr 01;12(2):263-78. doi: 10.5114/aoms.2016.59250. Epub 2016 Apr 11.

Mutations in NEBL encoding the cardiac Z-disk protein nebulette are associated with various cardiomyopathies.

Archives of medical science : AMS

Andreas Perrot, Pavol Tomasov, Eric Villard, Reka Faludi, Paola Melacini, Janine Lossie, Nadine Lohmann, Pascale Richard, Marzia De Bortoli, Annalisa Angelini, Akos Varga-Szemes, Silke R Sperling, Tamás Simor, Josef Veselka, Cemil Özcelik, Philippe Charron

Affiliations

  1. Charité-Universitätsmedizin Berlin, Cardiovascular Genetics, Experimental and Clinical Research Center, Berlin, Germany.
  2. Department of Cardiology, 2 Medical School, Charles University, University Hospital Motol, Prague, Czech Republic.
  3. AP-HP, Département de Génétique et Département de Cardiologie et Inserm UMR 1166, Hopital Pitié-Salpêtrière, Paris, France.
  4. Heart Institute, Faculty of Medicine, University of Pécs, Pécs, Hungary.
  5. Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.
  6. Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, UF Cardiogénétique et Myogénétique, Service de Biochimie Métabolique, Paris, France.
  7. Charité-Universitätsmedizin Berlin, Cardiovascular Genetics, Experimental and Clinical Research Center, Berlin, Germany; Knappschaftskrankenhaus Recklinghausen, Medizinischen Klinik I Kardiologie, Gastroenterologie und Diabetologie, Recklinghausen, Germany.
  8. AP-HP, Département de Génétique et Département de Cardiologie et Inserm UMR 1166, Hopital Pitié-Salpêtrière, Paris, France; Université de Versailles Saint Quentin en Yvelines, Versailles, France.

PMID: 27186169 PMCID: PMC4848357 DOI: 10.5114/aoms.2016.59250

Abstract

INTRODUCTION: Transgenic mice overexpressing mutated NEBL, encoding the cardiac-specific Z-disk protein nebulette, develop severe cardiac phenotypes. Since cardiomyopathies are commonly familial and because mutations in a single gene may result in variable phenotypes, we tested the hypothesis that NEBL mutations are associated with cardiomyopathy.

MATERIAL AND METHODS: We analyzed 389 patients, including cohorts of patients with dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), and left ventricular non-compaction cardiomyopathy (LVNC). The 28 coding exons of the NEBL gene were sequenced. Further bioinformatic analysis was used to distinguish variants.

RESULTS: In total, we identified six very rare heterozygous missense mutations in NEBL in 7 different patients (frequency 1.8%) in highly conserved codons. The mutations were not detectable in 320 Caucasian sex-matched unrelated individuals without cardiomyopathy and 192 Caucasian sex-matched blood donors without heart disease. Known cardiomyopathy genes were excluded in these patients. The mutations p.H171R and p.I652L were found in 2 HCM patients. Further, p.Q581R and p.S747L were detected in 2 DCM patients, while the mutation p.A175T was identified independently in two unrelated patients with DCM. One LVNC patient carried the mutation p.P916L. All HCM and DCM related mutations were located in the nebulin-like repeats, domains responsible for actin binding. Interestingly, the mutation associated with LVNC was located in the C-terminal serine-rich linker region.

CONCLUSIONS: Our data suggest that NEBL mutations may cause various cardiomyopathies. We herein describe the first NEBL mutations in HCM and LVNC. Our findings underline the notion that the cardiomyopathies are true allelic diseases.

Keywords: cardiomyopathy; dilated; genetics; hypertrophic; non-compaction

References

  1. Circulation. 2006 Apr 11;113(14):1807-16 - PubMed
  2. Arch Med Sci. 2011 Apr;7(2):242-6 - PubMed
  3. Eur Heart J. 1999 Jan;20(2):93-102 - PubMed
  4. Cell Tissue Res. 2007 Feb;327(2):353-69 - PubMed
  5. Circ Heart Fail. 2009 May;2(3):253-61 - PubMed
  6. Cell Motil Cytoskeleton. 1995;32(3):205-25 - PubMed
  7. Science. 2012 Jul 6;337(6090):64-9 - PubMed
  8. J Am Coll Cardiol. 2010 Mar 16;55(11):1136-8 - PubMed
  9. J Am Coll Cardiol. 2010 Oct 26;56(18):1503-5 - PubMed
  10. Hum Mutat. 2008 Jun;29(6):879-85 - PubMed
  11. J Cell Biol. 2001 Apr 16;153(2):413-27 - PubMed
  12. J Muscle Res Cell Motil. 2000 Feb;21(2):153-69 - PubMed
  13. Mol Genet Metab. 2008 Sep-Oct;95(1-2):74-80 - PubMed
  14. J Mol Med (Berl). 2005 Jun;83(6):468-77 - PubMed
  15. Cell Motil Cytoskeleton. 1999;44(1):1-22 - PubMed
  16. Eur J Heart Fail. 2007 Jan;9(1):4-6 - PubMed
  17. Nat Methods. 2010 Aug;7(8):575-6 - PubMed
  18. Nat Methods. 2010 Apr;7(4):248-9 - PubMed
  19. Exp Cell Res. 2002 Feb 15;273(2):204-18 - PubMed
  20. J Am Coll Cardiol. 2010 Oct 26;56(18):1493-502 - PubMed
  21. Cell Motil Cytoskeleton. 2007 Apr;64(4):258-73 - PubMed
  22. Cardiovasc Res. 2008 Jan;77(1):118-25 - PubMed
  23. Cell Motil Cytoskeleton. 2008 Feb;65(2):130-42 - PubMed
  24. Genome Biol. 2003;4(11):R72 - PubMed
  25. J Biol Chem. 2003 Jan 31;278(5):3089-97 - PubMed
  26. Exp Cell Res. 2008 Nov 15;314(19):3519-30 - PubMed
  27. Eur J Heart Fail. 2006 Aug;8(5):484-93 - PubMed
  28. Arch Med Sci. 2013 Aug 30;9(4):594-600 - PubMed
  29. Hum Genet. 2000 Nov;107(5):440-51 - PubMed
  30. J Mol Biol. 1998 Sep 11;282(1):111-23 - PubMed
  31. Circulation. 2003 May 6;107(17):2227-32 - PubMed
  32. Circ Cardiovasc Genet. 2012 Apr 1;5(2):167-74 - PubMed
  33. N Engl J Med. 2011 Apr 28;364(17):1643-56 - PubMed
  34. J Am Coll Cardiol. 2005 Jul 5;46(1):101-5 - PubMed

Publication Types